Literature DB >> 21886496

A screening tool to enhance clinical trial participation at a community center involved in a radiation oncology disparities program.

Julian W Proctor1, Elaine Martz, Larry L Schenken, Rebecca Rainville, Ursula Marlowe.   

Abstract

PURPOSE: To investigate the effectiveness of a screening tool to enhance clinical trial participation at a community radiation oncology center involved in a National Cancer Institute-funded disparities program but lacking on-site clinical trials personnel. PATIENTS AND METHODS: The screening form was pasted to the front of the charts and filled out for all new patients over the 9-month period of the study, during which time five external beam radiation therapy (EBRT) trials and a patient perception study were open for accrual. Patient consent was obtained by assorted personnel at several different sites. Patients potentially eligible for a trial were identified and approached by one of the clinic staff. Patients who were under- or uninsured, age > 80 years, members of an racial/ethnic minority, or recipients of medical assistance were identified as at risk for health care disparities and were offered patient navigator services.
RESULTS: Of 196 patients consulted during the study, 144 were treated with EBRT. Of the 24 patients eligible for EBRT trials, 23 were approached (one had an incomplete screening form), and 15 accepted. Of 77 patients eligible for a patient perception trial, 72 were approached (five had incomplete forms), and 45 accepted. The eligibility and acceptance rates for EBRT trials were similar for disparities and nondisparities patients. Screening was completed for 96 patients (67%).
CONCLUSION: When completed, the screening tool ensured clinical trial accrual. The major factor limiting overall accrual was a shortage of available trials.

Entities:  

Year:  2011        PMID: 21886496      PMCID: PMC3092655          DOI: 10.1200/JOP.2010.000135

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN: 1554-7477            Impact factor:   3.840


  15 in total

1.  The costs of conducting clinical research.

Authors:  Ezekiel J Emanuel; Lowell E Schnipper; Deborah Y Kamin; Jenifer Levinson; Allen S Lichter
Journal:  J Clin Oncol       Date:  2003-10-14       Impact factor: 44.544

2.  Researching the cost of research.

Authors:  James R Wright; Mark N Levine
Journal:  J Clin Oncol       Date:  2003-10-14       Impact factor: 44.544

Review 3.  Reducing cancer disparities for minorities: a multidisciplinary research agenda to improve patient access to health systems, clinical trials, and effective cancer therapy.

Authors:  Deborah Watkins Bruner; Michele Jones; David Buchanan; Jose Russo
Journal:  J Clin Oncol       Date:  2006-05-10       Impact factor: 44.544

4.  Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment.

Authors:  P N Lara; R Higdon; N Lim; K Kwan; M Tanaka; D H Lau; T Wun; J Welborn; F J Meyers; S Christensen; R O'Donnell; C Richman; S A Scudder; J Tuscano; D R Gandara; K S Lam
Journal:  J Clin Oncol       Date:  2001-03-15       Impact factor: 44.544

5.  Outcomes among African-Americans and Caucasians in colon cancer adjuvant therapy trials: findings from the National Surgical Adjuvant Breast and Bowel Project.

Authors:  J J Dignam; L Colangelo; W Tian; J Jones; R Smith; D L Wickerham; N Wolmark
Journal:  J Natl Cancer Inst       Date:  1999-11-17       Impact factor: 13.506

6.  Clinical trial accrual among new cancer patients at a community-based cancer center.

Authors:  Ronald S Go; Kathleen A Frisby; Jennifer A Lee; Michelle A Mathiason; Christine M Meyer; Jodi L Ostern; Sara M Walther; Jonean E Schroeder; Lori A Meyer; Kathryn E Umberger
Journal:  Cancer       Date:  2006-01-15       Impact factor: 6.860

7.  Assessment of "best practice" treatment patterns for a "radiation oncology community outreach group" engaged in cancer disparities outcomes.

Authors:  Regiane S de Andrade; Julian W Proctor; Susan M Rakfal; E Day Werts; Larry L Schenken; Cheng B Saw; Michael Dougherty; David Stefanik
Journal:  J Am Coll Radiol       Date:  2008-04       Impact factor: 5.532

Review 8.  Clinical trials in the community. The community clinical oncology program experience.

Authors:  C D Cobau
Journal:  Cancer       Date:  1994-11-01       Impact factor: 6.860

9.  Evaluation of Patient Navigation in a Community Radiation Oncology Center Involved in Disparities Studies: A Time-to-Completion-of-Treatment Study.

Authors:  Karen A Schwaderer; Julian W Proctor; Elaine F Martz; Robert J Slack; Edmund Ricci
Journal:  J Oncol Pract       Date:  2008       Impact factor: 3.840

10.  The Institute of Medicine report "Unequal Treatment": implications for academic health centers.

Authors:  Joseph R Betancourt; Angela W Maina
Journal:  Mt Sinai J Med       Date:  2004-10
View more
  8 in total

1.  Empowering Latina breast cancer patients to make informed decisions about clinical trials: a pilot study.

Authors:  Patricia Chalela; Edgar Muñoz; Kipling J Gallion; Virginia Kaklamani; Amelie G Ramirez
Journal:  Transl Behav Med       Date:  2018-05-23       Impact factor: 3.046

2.  Use of the National Cancer Institute Community Cancer Centers Program screening and accrual log to address cancer clinical trial accrual.

Authors:  Diane St Germain; Andrea M Denicoff; Eileen P Dimond; Angela Carrigan; Rebecca A Enos; Maria M Gonzalez; Kathy Wilkinson; Michelle A Mathiason; Brenda Duggan; Shaun Einolf; Worta McCaskill-Stevens; Donna M Bryant; Michael A Thompson; Stephen S Grubbs; Ronald S Go
Journal:  J Oncol Pract       Date:  2014-01-14       Impact factor: 3.840

3.  Patient Navigation As a Model to Increase Participation of African Americans in Cancer Clinical Trials.

Authors:  Mona N Fouad; Aras Acemgil; Sejong Bae; Andres Forero; Nedra Lisovicz; Michelle Y Martin; Gabriela R Oates; Edward E Partridge; Selwyn M Vickers
Journal:  J Oncol Pract       Date:  2016-05-17       Impact factor: 3.840

4.  The National Cancer Institute-American Society of Clinical Oncology Cancer Trial Accrual Symposium: summary and recommendations.

Authors:  Andrea M Denicoff; Worta McCaskill-Stevens; Stephen S Grubbs; Suanna S Bruinooge; Robert L Comis; Peggy Devine; David M Dilts; Michelle E Duff; Jean G Ford; Steven Joffe; Lidia Schapira; Kevin P Weinfurt; Margo Michaels; Derek Raghavan; Ellen S Richmond; Robin Zon; Terrance L Albrecht; Michael A Bookman; Afshin Dowlati; Rebecca A Enos; Mona N Fouad; Marjorie Good; William J Hicks; Patrick J Loehrer; Alan P Lyss; Steven N Wolff; Debra M Wujcik; Neal J Meropol
Journal:  J Oncol Pract       Date:  2013-10-15       Impact factor: 3.840

Review 5.  State-of-the-science of patient navigation as a strategy for enhancing minority clinical trial accrual.

Authors:  Rahel G Ghebre; Lovell A Jones; Jennifer A Wenzel; Michelle Y Martin; Raegan W Durant; Jean G Ford
Journal:  Cancer       Date:  2014-04-01       Impact factor: 6.860

6.  Development of a framework to improve the process of recruitment to randomised controlled trials (RCTs): the SEAR (Screened, Eligible, Approached, Randomised) framework.

Authors:  Caroline Wilson; Leila Rooshenas; Sangeetha Paramasivan; Daisy Elliott; Marcus Jepson; Sean Strong; Alison Birtle; David J Beard; Alison Halliday; Freddie C Hamdy; Rebecca Lewis; Chris Metcalfe; Chris A Rogers; Robert C Stein; Jane M Blazeby; Jenny L Donovan
Journal:  Trials       Date:  2018-01-19       Impact factor: 2.279

7.  Overcoming Barriers to Clinical Trial Participation: Outcomes of a National Clinical Trial Matching and Navigation Service for Patients With a Blood Cancer.

Authors:  Maria Sae-Hau; Kate Disare; Margo Michaels; Alissa Gentile; Leah Szumita; Katherine Treiman; Elisa S Weiss
Journal:  JCO Oncol Pract       Date:  2021-06-02

8.  Removing barriers to participation in clinical trials, a conceptual framework and retrospective chart review study.

Authors:  Norma F Kanarek; Marty S Kanarek; Dare Olatoye; Michael A Carducci
Journal:  Trials       Date:  2012-12-10       Impact factor: 2.279

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.